Recently, the application practice of the AI-ROSE intelligent auxiliary analysis system created by Shanghai Xingmai Information Technology Co., Ltd. (hereinafter referred to as Fosun Xingmai), a Jiading enterprise, won the "Shencheng Theory 2022 Shanghai Urban Digital Transformation Top Ten Excellent Application Cases", which is also the only selected artificial intelligence medical enterprise case.
According to reports, the "Tracheoscopy AI-ROSE Intelligent Auxiliary Analysis System" developed by Fosun Xingmai is composed of two parts: automatic digital microscope and artificial intelligence analysis software, which can combine artificial intelligence deep learning with on-site rapid diagnosis technology, and the interpretation time is only about 2 minutes. From the interpretation results, the puncture specimens can be objectively and accurately evaluated for quality, nature judgment and diagnostic classification, so as to reduce the adverse effects of human subjective bias on clinical diagnosis and treatment as much as possible.
"This system can help doctors improve diagnostic efficiency and accuracy, and get rid of the limitations of traditional technology on senior pathologists." If it is extended to grassroots hospitals and remote areas with relatively few medical resources, it can help more clinicians formulate accurate diagnosis and treatment plans in a timely manner. Medina, brand director of Fosun Xingmai, said.
At present, Fosun Xingmai has established long-term cooperation with Zhongshan Hospital affiliated to Fudan University to explore the optimization and acceleration of bronchoscopic biopsy process. Hu Qin, a pathologist at the hospital, said that after long-term comparison of diagnostic results, the accuracy of Fosun's Xingmai artificial intelligence device was slightly higher than that of primary cell pathologists.
It is understood that Fosun Xingmai is the first artificial intelligence medical enterprise in China to realize the integration of "radiology, pathology, ultrasound, cardiac, respiratory, orthopedics, neurology, nail and breast surgery" and other multi-disciplines, and has reached industrial cooperation with more than 500 well-known medical institutions at home and abroad. Since settling in Jiading for more than one year, the company has obtained more than 10 medical device licenses at home and abroad, served more than 30 million times in hospitals at all levels across the country, and obtained more than 110 patents.
Source: Shanghai Jiading